Page last updated: 2024-08-26

3-aminobenzeneboronic acid and cefuroxime

3-aminobenzeneboronic acid has been researched along with cefuroxime in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giske, CG; Kalin, M; Källman, O; Olsson-Liljequist, B; Samuelsen, Ø; Wretlind, B	1

Other Studies

1 other study(ies) available for 3-aminobenzeneboronic acid and cefuroxime

Article	Year
Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli. Microbial drug resistance (Larchmont, N.Y.), 2009, Volume: 15, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Cefuroxime; Cell Membrane Permeability; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Reverse Transcriptase Polymerase Chain Reaction	2009

Article

Year

Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli.

Microbial drug resistance (Larchmont, N.Y.), 2009, Volume: 15, Issue:2

Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Cefuroxime; Cell Membrane Permeability; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Lipoproteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Reverse Transcriptase Polymerase Chain Reaction

2009